Otsuka Pharmaceutical Co., Ltd.
 |
|
|
Native name
|
大塚製薬株式会社 |
|---|---|
|
Romanized name
|
Ōtsuka Seiyaku Kabushiki-gaisha |
| Public (K.K.) | |
| Traded as | : TOPIX 100 Component |
| Founded | 1964; 53 years ago |
| Headquarters | Chiyoda, Tokyo, Japan |
|
Key people
|
Tatsuo Higuchi (President) |
|
Number of employees
|
25,330 (2013) |
| Parent | Otsuka Holdings Co. Ltd |
| Website | otsuka.com |
Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社 Ōtsuka Seiyaku Kabushiki-gaisha?) (: ), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964. As of 2012[update], OPC employed 40,000 people worldwide. The company focuses on pharmaceuticals related to nutrition (or "nutraceuticals"). The company is also known for the popular sports drink Pocari Sweat and the best-selling energy drink Oronamin C. Otsuka Pharmaceutical also developed Abilify (aripiprazole), an approved drug treatment for schizophrenia and bipolar disorder, which they claim has a better side effect profile compared with other antipsychotic drugs. As of 2013[update], annual sales of Abilify were over $8 billion a year, making it the highest grossing drug worldwide as of late 2013.
OPC's parent company Otsuka Holdings Co. Ltd. joined the through an initial public offering (IPO) on December 15, 2010, at which time Otsuka Holdings was Japan's No.2 drug maker by sales after industry leader Takeda Pharmaceutical Company. The IPO debuted at $2.4 billion, making it the largest for a pharmaceutical company up to that time.
...
Wikipedia